Series A - Fount Bio

Series A - Fount Bio

Investment Firm

Overview

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Announced Date

Jul 01, 2021

Closed on Date

Jul 01, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Morningside Venture Investments

Morningside Venture Investments

Morningside Venture Investments is a private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorMorningside Venture Investments

Round Details and Background

Fount Bio raised $8157203 on 2021-07-01 in Series A

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 01, 2021
Series A - Fount Bio
1-8.2M

Recent Activity

There is no recent news or activity for this profile.